Search research articles
Contact Us
Filters
Showing results (451-460 of 521) with videos related to
Page
of 53
Sort By:
NPJ Precision Oncology
|
June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence
Sebastian Cole, Paul Campitelli, Brian Grieb, et al.
World Journal of Gastroenterology
|
March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment
Philip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2016
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
H H Yoon, J C Bendell, F S Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2019
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Ramesh K Ramanathan, Shannon L McDonough, Philip A Philip, et al.
Complementary Therapies in Clinical Practice
|
April 9, 2008
Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Yasunori Maeda, Anne Loughrey, J A Philip Earle, et al.
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 2, 2020
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
H H Yoon, J C Bendell, F S Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205
Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
The American Journal of Gastroenterology
|
November 11, 2018
High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer
Shounak Majumder, Nissy A Philip, Sajan Jiv Singh Nagpal, et al.
Page
of 53
Search research articles
Search
Showing results (451-460 of 521) with videos related to
Sort By:
Page
of 53
NPJ Precision Oncology
|
June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence
Sebastian Cole, Paul Campitelli, Brian Grieb, et al.
World Journal of Gastroenterology
|
March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Jonathan R Strosberg, George A Fisher, Al B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment
Philip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2016
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
H H Yoon, J C Bendell, F S Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2019
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Ramesh K Ramanathan, Shannon L McDonough, Philip A Philip, et al.
Complementary Therapies in Clinical Practice
|
April 9, 2008
Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Yasunori Maeda, Anne Loughrey, J A Philip Earle, et al.
Oncogene
|
May 26, 2022
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets
Alberto Puccini, Kelsey Poorman, Fabio Catalano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 2, 2020
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
H H Yoon, J C Bendell, F S Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205
Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
The American Journal of Gastroenterology
|
November 11, 2018
High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer
Shounak Majumder, Nissy A Philip, Sajan Jiv Singh Nagpal, et al.
Page
of 53